Maravai LifeSciences Holdings, Inc. (MRVI) vs Vir Biotechnology, Inc. (VIR)
- Maravai LifeSciences Holdings, Inc. MRVI 6.79 −3.96%
- Vir Biotechnology, Inc. VIR 9.96 −4.87%
Maravai LifeSciences Holdings, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against −5.03%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −83.0%) and the higher return on invested capital (−15.8% vs −39.1%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 10 and Vir Biotechnology, Inc. on 8.
Valuation
Profitability
| Metric | MRVI | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | 100.00% | 65.16% |
| Operating margin | (56.08%) | (92.40%) | 0.00% |
| Net margin | (37.07%) | (83.00%) | 0.00% |
| Free cash flow margin | (17.17%) | (67.17%) | 0.00% |
| Return on equity | (18.79%) | (26.08%) | (56.36%) |
| Return on assets | (10.31%) | (20.91%) | (48.04%) |
| Return on invested capital | (15.83%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack